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BERIT SJÖDEN,2 AND RICHARD R. FACKLAM3*
Department of Food Science and Technology, University of Reading, Reading,
United Kingdom1; Culture Collection, Department of Clinical Bacteriology,
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Three strains of a gram-positive catalase-negative, facultatively anaerobic coccus-shaped organism origi-
nating from human clinical samples were characterized by phenotypic and molecular taxonomic methods.
Sequencing of genes encoding 16S rRNA showed that the strains are phylogenetically closely related (99.9 to
100% sequence similarity) and represent a new subline within the genus Facklamia. The unknown bacterium
was readily distinguished from all currently described species of the genus Facklamia (viz., Facklamia hominis,
Facklamia ignava, and Facklamia sourekii) by biochemical tests and electrophoretic analysis of whole-cell pro-
teins. Based on phylogenetic and phenotypic evidence, it is proposed that the unknown bacterium be classified
as Facklamia languida sp. nov. The type strain of F. languida is CCUG 37842.
Over the past few years there has been a considerable ex-
pansion in the number of genera and species of aerobic or
facultatively anaerobic catalase-negative gram-positive cocci
identified from human clinical sources. Much of this change
has stemmed from the increased use of molecular genetic (e.g.,
16S rRNA gene sequencing) and molecular chemical (e.g.,
whole-cell protein analysis) methodologies for the identifica-
tion of these organisms from clinical samples. In particular,
16S rRNA gene sequencing has resulted in phylogenetically
based descriptive frameworks, which, together with rapid se-
quencing technology and readily accessible sequence libraries,
are providing diagnostic laboratories with immensely powerful
technology for identifying not only atypical or problematic
members of existing taxa but also a wealth of new and diverse
organisms. Examples of new catalase-negative gram-positive
cocci from human sources include Abiotrophia elegans (16),
Aerococcus urinae (1), Alloiococcus otitis (2), Dolosigranulum
pigrum (3), Facklamia hominis (5), Facklamia ignava (10), Ge-
mella bergeri (9), Gemella sanguinis (8), Globicatella sanguinis
(4), Helcococcus kunzii (6), and Ignavigranum ruoffiae (11).
During an investigation of atypical gram-positive catalase-neg-
ative chain-forming cocci from human sources, we have en-
countered three Facklamia-like isolates from clinical materials.
Preliminary biochemical studies indicated that these strains did
not conform to any of the currently recognized species of this
genus, viz., F. hominis (5), F. ignava (10), and F. sourekii (7). In
this paper, we report the phenotypic characteristics of these
clinical isolates and the results of a molecular genetic and
molecular chemical analysis. Based on the findings presented
here, we consider the unknown chain-forming coccus to rep-
resent a new species of the genus Facklamia, for which the
name F. languida sp. nov. is described.
Two strains (1144-97 and 1664-95) from human sources
were referred to the Centers for Disease Control and Preven-
tion (Atlanta, Ga.) for identification. Strain 1144-97 (Culture
Collection of the University of Göteborg, CCUG 37842T) was
recovered from a blood culture of a 5-year-old female child
with bacteremia in Ohio. Strain 1664-95 (5CCUG 37420) was
received from Marguerite Lovegren (Edmonton, Canada) and
originated from blood cultures of a 74-year-old woman with a
urinary tract infection. Strain CCUG 30940 was submitted by
the Public Health Laboratory Service in Göteborg (Sweden) to
the Culture Collection of the University of Göteborg for iden-
tification and originated from cerebrospinal fluid in a 40-year-
old woman. No additional clinical information is available on
the three strains. The unidentified organisms were cultured on
Columbia agar (Difco, Detroit, Mich.) supplemented with 5%
defibrinated horse blood (Oxoid, Unipath Ltd., Basingstoke,
United Kingdom) at 37°C, in air plus 5% CO2. The strains
were biochemically characterized by using the API rapid
ID32S and API ZYM systems according to the manufacturer’s
instructions (API bioMérieux, Marcy l’Etoile, France). Conven-
tional physiological tests were also conducted as described by
Facklam and Elliott (13). Polyacrylamide gel electrophoresis
(PAGE) analysis of whole-cell proteins was performed as de-
scribed by Pot et al. (15). For densitometric analysis, normal-
ization, and interpretation of protein patterns the GelCompar
GCW 3.0 software package (Applied Maths, Kortrijk, Bel-
gium) was used. The similarity between all pairs of traces was
expressed by the Pearson product moment correlation coeffi-
cient converted for convenience to a percentage similarity value.
Phylogenetic analysis was conducted by 16S rRNA gene se-
quencing. A large fragment of the 16S rRNA gene was ampli-
fied by PCR using conserved primers close to the 39 and 59 ends
of the gene and directly sequenced with a Taq Dye-Deoxy ter-
minator cycle sequencing kit (Applied Biosystems, Foster City,
Calif.) and an automatic DNA sequencer (model 373A; Ap-
plied Biosystems). The closest known relatives of the new iso-
late were determined by performing database searches. These
sequences and those of other known related strains were re-
trieved from the GenBank or Ribosomal Database Project li-
braries and aligned with the newly determined sequence by us-
ing the program PILEUP (12). The resulting multiple-sequence
alignment was corrected manually, and a distance matrix was
calculated by using the programs PRETTY and DNADIST
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(using the Kimura-2 correction parameter) (14). A phyloge-
netic tree was constructed according to the neighbor-joining
method with the program NEIGHBOR, and the stability of
the groupings was estimated by bootstrap analysis (500 rep-
lications) by using the programs DNABOOT, DNADIST,
NEIGHBOR, and CONSENSE (14).
On Trypticase soy agar containing 5% sheep blood (TSA-
SB) (Becton Dickinson Co., Cockeysville, Md.), after 24 h
of incubation in an atmosphere of increased CO2, the isolates
formed small gray to colorless colonies with little hemolytic
activity on the sheep blood cells. After 48 h of incubation the
colonies were surrounded by a small zone of alpha hemolysis.
All three isolates were ovoid and most commonly formed pairs,
but single cells and short chains were also observed. They were
gram positive, non-spore forming, catalase negative, oxidase
negative, and facultatively anaerobic. The strains grew in 6.5%
NaCl at 37°C but not at all at 10 or 45°C and were pyrroli-
donyl arylamidase and leucine aminopeptidase positive in
conventional tests (13). The three isolates gave the profile
00020500000 with the API rapid ID32S strip and corresponded
to a doubtful profile. Significant taxa were Gemella morbillo-
rum (four tests against) and Gemella haemolysans (three tests
against). When commercial API systems were used, the iso-
lates produced acid from trehalose but failed to produce acid
from D-arabitol, L-arabinose, cyclodextrin, glycogen, lactose,
maltose, mannitol, melibiose, melezitose, pullulan, raffin-
ose, ribose, sorbitol, sucrose, tagatose, or methyl-b-D-glucopy-
ranoside. Alkaline phosphatase, pyroglutamic acid arylami-
dase, leucine arylamidase, and glycyl-tryptophan arylamidase
activities were detected. No activity was detected for arginine
dihydrolase, acid phosphatase, alanine-phenylalanine-proline
arylamidase, b-galacturonidase, a-galactosidase, b-galacto-
sidase, b-glucuronidase, a-glucosidase, b-glucosidase, lipase
C14, a-fucosidase, a-mannosidase, b-mannosidase, N-acetyl-
glucosaminidase, cysteine arylamidase, chymotrypsin, trypsin,
or urease. Esterase C4 and ester lipase C8 activity was found to
be variable. The strains did not hydrolyze hippurate and were
Voges-Proskauer negative. A numerical analysis of the whole-
FIG. 1. Similarity dendrogram based on whole-cell protein pattern of F. languida sp. nov. and related species. Levels of correlation are expressed as percentages
for convenience.
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cell protein patterns of the three clinical strains along with a
comprehensive range of other gram-positive catalase-negative
reference organisms is shown in Fig. 1. The three strains
formed a distinct cluster grouping at a correlation level of
approximately 80%. The PAGE groupings nearest to the un-
known bacterium were formed by strains of F. hominis and
F. ignava. It is very evident from the protein analysis that the
unknown coccus is distinct from the aforementioned species
and all the other reference species examined, including Abio-
trophia spp., Aerococcus spp., Alloiococcus otitis, Carnobacte-
rium spp., D. pigrum, Gemella spp., and Globicatella sanguinis
(Fig. 1). To assess the phylogenetic relations of the unknown
clinical isolates, their 16S rRNA gene sequences were deter-
mined and subjected to comparative analysis. Over 1,440 bases
were determined, and pairwise analysis revealed that the 16S
rRNA genes of the three strains were 99.9 to 100% similar
(corresponding to 0 or 1 base difference). Sequence searches of
GenBank and Ribosomal Database Project libraries revealed
that the unknown coccus was phylogenetically most closely as-
sociated with the lactic acid group of bacteria. Closely related
sequences were retrieved, and a tree constructed by neighbor-
joining depicting the phylogenetic affinity of the unknown coc-
cus as exemplified by strain CCUG 37842T is shown in Fig. 2.
The unknown bacterium clustered within the Facklamia clade,
and from the branching pattern it is evident that F. hominis is
its closest phylogenetic relative. Indeed, the clustering of these
organisms occurred in 100% of 500 tree replications. Despite
the statistically significant association between the unknown
bacterium and F. hominis, pairwise comparisons showed that
the 16S rRNA of the unknown organism possessed 44 (strains
CCUG 37842T and CCUG 37420) or 43 (strain CCUG 30940)
base differences (based on 1,440 positions) with F. hominis
(equivalent to 3% 16S rRNA sequence divergence).
It is evident from comparative 16S rRNA gene sequencing
that the unidentified organism from clinical material repre-
sents a new subline within the genus Facklamia, close to, but
distinct from, F. hominis. 16S rRNA sequence divergence
values of 3% or more between the unknown bacterium and
F. hominis, F. ignava, and F. sourekii unequivocally demon-
strate that the bacterium represents a hitherto-unknown Fack-
lamia species. It is pertinent that the three currently known
Facklamia species have all been isolated from human clinical
FIG. 2. Unrooted tree showing the phylogenetic relationships of F. languida sp. nov. and some other low-G1C gram-positive bacteria. The tree was constructed
by the neighbor-joining method and was based on a comparison of approximately 1,320 nucleotides. Bootstrap values, expressed as percentages of 500 replications, are
given at branching points. Abbreviations: ATCC, American Type Culture Collection; DSM, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; IAM,
Institute of Applied Microbiology; JCM, Japanese Collection of Microorganisms; NCDO, National Collection of Dairy Organisms; NCFB, National Collection of Food
Bacteria; NCMIB, National Collection of Industrial and Marine Bacteria.
TABLE 1. Characteristics differentiating F. languida sp. nov.
from other Facklamia speciesa
Test F. sourekii F. ignava F. hominis F. languidasp. nov.
Acid from:
D-Arabitol 1 2 2 2
Maltose 1 2 2 2
Mannitol 1 2 2 2
Sorbitol 1 2 2 2
Sucrose 1 2 2 2
Trehalose 1 V 2 1
Production of:
Arginine dihydrolase 2 2 1 2
Alanine-phenylalanine-
proline arylamidase
2 1 1 2
a-Galactosidase 2 2 1 2
b-Galactosidase 2 2 1 2
Glycyl-tryptophan aryl-
amidase
2 2 V 1
Hydrolysis of hippurate 1 1 1 2
a V, variable.
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material. F. hominis, the type species of the genus, was de-
scribed by Collins et al. (5) for some strains of chain-forming
cocci isolated from a variety of specimens, including blood,
urine, abscesses, and vaginal swabs. Similarly, F. ignava and
F. sourekii also originated from human clinical sources (7, 10).
The strains characterized in the present study clearly represent
yet another member of this new genus recovered from clinical
specimens. The three human isolates of this novel species were
biochemically closely related to each other, and PAGE analysis
of whole-cell proteins further demonstrated their high overall
phenotypic homogeneity. Although displaying a close phyloge-
netic affinity with F. hominis, the unknown coccus could be
readily distinguished from this species, in producing acid from
trehalose, failing to hydrolyze hippurate, and not displaying
arginine dihydrolase, alanine-phenylalanine-proline arylami-
dase, a-galactosidase, or b-galactosidase activity. Similarly, the
unknown bacterium biochemically differs from F. ignava in
producing glycyl-tryptophan arylamidase but not alanine-phe-
nylalanine-proline arylamidase and from F. sourekii in failing
to produce acid from a wide range of carbohydrates, viz., D-
arabitol, maltose, mannitol, sorbitol, and sucrose, and by not
hydrolyzing hippurate. Based on the results of the comparative
16S rRNA analysis and the distinct electrophoretic protein
patterns and biochemical reactions of the unknown coccus, we
consider that the bacterium merits classification as a new spe-
cies, for which the name Facklamia languida (languida, per-
taining to the organism’s lack of activity in the biochemical
tests used) is proposed. Tests which distinguish F. languida sp.
nov. from other members of the genus Facklamia are summa-
rized in Table 1.
Description of Facklamia languida sp. nov. On TSA-SB after
24 h of incubation in air plus CO2, small grey to colorless
colonies which show little hemolytic activity are formed. After
48 h of incubation, colonies are surrounded by a small zone of
alpha hemolysis. Cells are ovoid and usually form pairs, but
single cells and short chains may also occur. Facultatively an-
aerobic and catalase and oxidase negative. Grows in 6.5%
NaCl at 37°C. Does not grow at 10 or 45°C. Pyrrolidonyl
arylamidase and leucine aminopeptidase positive in conven-
tional tests. In commercial API systems acid is produced from
trehalose. Acid is not produced from D-arabitol, L-arabinose,
cyclodextrin, glycogen, lactose, melibiose, mannitol, maltose,
melezitose, methyl-b-D-glucopyranoside, pullulan, raffinose,
ribose, sorbitol, sucrose, or tagatose. Alkaline phosphatase,
pyroglutamic acid arylamidase, leucine arylamidase, and glyc-
yl-tryptophan arylamidase activities are detected. Acid phos-
phatase, alanine-phenylalanine-proline arylamidase, arginine
dihydrolase, N-acetyl-b-glucosaminidase, chymotrypsin, tryp-
sin, cysteine arylamidase, a-fucosidase, a-galactosidase, b-ga-
lactosidase, b-galacturonidase, a-glucosidase, b-glucosidase,
b-glucuronidase, lipase C14, a-mannosidase, b-mannosidase,
and urease activities are not detected. Esterase C4 and ester
lipase C8 may or may not be detected. Acetoin is not produced.
Hippurate is not hydrolyzed. Isolated from human clinical
specimens. Habitat is not known. The type strain is CCUG
37842T.
Nucleotide sequence accession number. The 16S rRNA gene
sequence of strain CCUG 37842T has been deposited in Gen-
Bank under accession no. Y18053.
We are grateful to Hans Trüper (University of Bonn, Bonn, Ger-
many) for coining the species epithet, and we also thank the depositors
of the strains. The excellent technical assistance of Lena Dahl is ac-
knowledged.
REFERENCES
1. Aguirre, M., and M. D. Collins. 1992. Phylogenetic analysis of some Aero-
coccus-like organisms from urinary tract infections: description of Aerococ-
cus urinae sp. nov. J. Gen. Microbiol. 138:401–405.
2. Aguirre, M., and M. D. Collins. 1992. Phylogenetic analysis of Alloiococcus
otitis gen. nov., sp. nov., an organism from human middle ear fluid. Int. J.
Syst. Bacteriol. 42:79–83.
3. Aguirre, M., D. Morrison, B. D. Cookson, F. W. Gay, and M. D. Collins.
1993. Phenotypic and phylogenetic characterization of some Gemella-like
organisms from human infections: description of Dolosigranulum pigrum gen.
nov., sp. nov. J. Appl. Bacteriol. 75:608–612.
4. Collins, M. D., M. Aguirre, R. R. Facklam, J. Shallcross, and A. M. Williams.
1992. Globicatella sanguis gen. nov., sp. nov., a new gram-positive catalase-
negative bacterium from human sources. J. Appl. Bacteriol. 73:422–437.
5. Collins, M. D., E. Falsen, J. Lemozy, E. Åkervall, B. Sjödén, and P. A.
Lawson. 1997. Phenotypic and phylogenetic characterization of some Glo-
bicatella-like organisms from human sources: description of Facklamia homi-
nis gen. nov., sp. nov. Int. J. Syst. Bacteriol. 47:880–882.
6. Collins, M. D., R. R. Facklam, U. M. Rodrigues, and K. L. Ruoff. 1993. Phy-
logenetic analysis of some Aerococcus-like organisms from clinical sources:
description of Helcoccus kunzii gen. nov., sp. nov. Int. J. Syst. Bacteriol. 43:
425–429.
7. Collins, M. D., R. A. Hutson, E. Falsen, and B. Sjöden. Facklamia sourekii sp.
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